Skip to main content
OSUR
NASDAQ Industrial Applications And Services

OraSure Technologies Resolves Activist Campaign, Appoints New Director, and Commits to Board Declassification

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.2
Mkt Cap
$221.895M
52W Low
$2.08
52W High
$3.82
52W Position info
54% above low
Off High info
16% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

OSUR sits 54% above its 52-week low of $2.08.

Summary

OraSure Technologies reached a cooperation agreement with activist investor Altai Capital, appointing a new independent director and agreeing to propose board declassification, averting a proxy fight.


Key Events · Corporate Governance and Compliance · OSUR

  • Cooperation Agreement Reached with Activist Investor

    OraSure Technologies entered into a cooperation agreement with Altai Capital Management, L.P., a 5.2% beneficial owner, resolving Altai's prior director nominations and stockholder proposal.

  • New Independent Director Appointed

    John D. Bertrand, a healthcare technology executive with AI-enabled diagnostics experience, was appointed as a Class II independent director to the Board and the Nominating and Corporate Governance Committee.

  • Commitment to Board Declassification

    The company will seek shareholder approval at the 2026 Annual Meeting to amend its Charter to declassify the Board, phasing in annual director elections.

  • Standstill and Voting Agreement

    Altai Capital agreed to a standstill provision and will vote its shares in accordance with the Board's recommendations until March 31, 2027, or earlier under certain conditions.


Analysis · OSUR · Industrial Applications And Services

OraSure Technologies has entered into a cooperation agreement with activist investor Altai Capital Management, resolving a potential proxy contest. This agreement brings stability by adding a new independent director with expertise in AI-enabled diagnostics, which is highly relevant to the company's sector. Furthermore, the commitment to seek shareholder approval for board declassification is a significant corporate governance enhancement, often favored by institutional investors, and addresses a common activist demand. This resolution and strategic board addition come after the company reported significant net losses and revenue decline for fiscal year 2025, suggesting a proactive step towards improving governance and strategic oversight during a challenging period.

At the time of this filing, OSUR was trading at $3.20 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $221.9M. The 52-week trading range was $2.08 to $3.82. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OSUR - Latest Insights

OSUR
Jul 21, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.93
Real-time Price: $3.97 info
Change: +$0.040 (+1%) info
Market Cap: $273.329M info
OSUR
Jun 11, 2026, 9:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.11
Real-time Price: $3.97 info
Change: -$0.140 (-3%) info
Market Cap: $273.329M info
OSUR
Jun 11, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.15
Real-time Price: $3.97 info
Change: -$0.180 (-4%) info
Market Cap: $273.329M info
OSUR
Jun 03, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.95
Real-time Price: $3.97 info
Change: +$0.020 (+0.51%) info
Market Cap: $273.329M info
OSUR
May 08, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.06
Real-time Price: $3.97 info
Change: +$0.910 (+30%) info
Market Cap: $273.329M info